Skip to content
drillr.ai
Sign up

ONCY

Oncolytics Biotech Inc.

NASDAQ · Healthcare · Biotechnology · CA

$0.84
−1.55%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue—————
Gross Profit—————
Operating Expenses
R&D Expense17.2M13.3M15.4M13.3M11.4M
SG&A Expense21.2M15.4M10.1M11.8M8.2M
General & Admin Expense21.2M15.4M10.1M11.8M8.2M
Selling & Marketing Expense—————
Other Expenses(137.2K)——303.8K288.8K
Total Operating Expenses38.3M28.7M25.5M25.5M19.8M
Cost and Expenses38.3M28.7M25.5M25.5M19.8M
Operating Income (EBIT)(38.3M)(28.7M)(25.5M)(25.5M)(19.8M)
Non-Operating
Interest Income262.0K529.6K1.2M1.3M528.0K
Interest Expense—————
Net Interest Income262.0K529.6K1.2M1.3M528.0K
Other Non-Op Income/Expense165.5K45.0K2.8M4.6M1.6M
Non-Operating Income (excl Interest)(38.0K)————
EBT (Pre-Tax Income)(38.1M)(28.7M)(22.7M)(20.8M)(18.2M)
Income Tax Expense118.9K79.0K95.0K73.1K61.9K
Bottom Line
Net Income(38.2M)(28.8M)(22.8M)(20.9M)(18.3M)
Earnings from Cont. Ops(38.2M)(28.8M)(22.8M)(20.9M)(18.3M)
Earnings from Discont. Ops—————
Bottom Line Net Income(38.2M)(28.8M)(22.8M)(20.9M)(18.3M)
Per Share
Basic EPS($0.34)($0.41)($0.30)($0.41)($0.44)
Diluted EPS($0.34)($0.41)($0.30)($0.41)($0.44)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding119.7M95.9M76.5M67.6M58.0M
Diluted Shares Outstanding119.7M95.9M76.5M67.6M58.0M
Profitability Metrics
EBITDA(38.1M)(28.7M)(25.5M)(25.2M)(19.5M)
D&A97.8K70.0K87.0K303.8K288.8K
EBIT(38.2M)(28.7M)(25.5M)(25.5M)(19.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026